Equities analysts forecast that Sanofi (NYSE:SNY) will report earnings of $0.75 per share for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Sanofi’s earnings. The highest EPS estimate is $0.78 and the lowest is $0.72. Sanofi reported earnings per share of $0.74 during the same quarter last year, which indicates a positive year over year growth rate of 1.4%. The company is scheduled to announce its next quarterly earnings results before the market opens on Monday, July 31st.
According to Zacks, analysts expect that Sanofi will report full year earnings of $3.20 per share for the current year, with EPS estimates ranging from $3.18 to $3.24. For the next fiscal year, analysts forecast that the company will post earnings of $3.36 per share, with EPS estimates ranging from $3.22 to $3.46. Zacks Investment Research’s EPS averages are a mean average based on a survey of research firms that cover Sanofi.
Sanofi (NYSE:SNY) last posted its quarterly earnings results on Friday, April 28th. The company reported $0.76 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.73 by $0.03. Sanofi had a net margin of 26.55% and a return on equity of 25.89%. The company had revenue of $8.65 billion for the quarter, compared to the consensus estimate of $8.40 billion. Sanofi’s revenue was up 1.2% on a year-over-year basis.
A number of equities research analysts recently weighed in on the company. Argus increased their price target on Sanofi from $50.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, June 9th. TheStreet upgraded Sanofi from a “c+” rating to a “b-” rating in a research note on Monday, April 24th. Zacks Investment Research cut Sanofi from a “buy” rating to a “hold” rating in a research note on Tuesday, April 25th. BidaskClub cut Sanofi from a “buy” rating to a “hold” rating in a research report on Wednesday, July 5th. Finally, Berenberg Bank cut Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, May 11th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and five have given a buy rating to the company’s stock. Sanofi presently has a consensus rating of “Hold” and an average target price of $67.67.
WARNING: “Analysts Anticipate Sanofi (NYSE:SNY) to Announce $0.75 EPS” was first reported by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at https://www.com-unik.info/2017/08/19/analysts-anticipate-sanofi-nysesny-to-announce-0-75-eps-updated-updated-updated.html.
Hedge funds and other institutional investors have recently modified their holdings of the company. Harbour Capital Advisors LLC acquired a new stake in Sanofi during the first quarter valued at $113,000. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its stake in Sanofi by 6,188.3% in the first quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 3,773 shares of the company’s stock valued at $171,000 after buying an additional 3,713 shares during the period. BLB&B Advisors LLC acquired a new stake in Sanofi during the first quarter valued at $202,000. Huntington National Bank raised its stake in Sanofi by 3.4% in the first quarter. Huntington National Bank now owns 4,455 shares of the company’s stock valued at $202,000 after buying an additional 147 shares during the period. Finally, New England Research & Management Inc. acquired a new stake in Sanofi during the first quarter valued at $208,000. Institutional investors own 9.97% of the company’s stock.
Sanofi (NYSE:SNY) remained flat at $47.71 on Friday. The stock had a trading volume of 1,179,870 shares. The firm has a market cap of $120.49 billion, a PE ratio of 11.50 and a beta of 0.89. The company’s 50-day moving average price is $48.25 and its 200 day moving average price is $45.52. Sanofi has a one year low of $36.81 and a one year high of $50.24.
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about Sanofi? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Sanofi and related companies.